Thierry André

ORCID iD
https://orcid.org/0000-0002-5103-7095

Biography

Thierry André is Professor of Medical Oncology at University Sorbonne Universités, (Paris VI), in Paris and at the Head and a senior physician, of the Medical Oncology (GI Oncology) department in Saint Antoine Hospital, Assistance Publique Hôpitaux de Paris since 2011. He received his MD in 1991 and trained in medical oncology at the University of Paris. He is a Founder, and Vice President of GERCOR Group. He is president of the scientific comitee of the ARCAD foundation. He is member of the Adjuvant Colon Cancer Endpoints (ACCENT) Group, the American Society of Clinical Oncology (ASCO), and the European Society of Medical Oncology (ESMO). He served or as served on the ASCO, ESMO educational comitee. Professor André’s main research interest is GI malignancies, and particularly the treatment of colo-rectal cancer. Dr André is the chief or principal investigator of multiple phase1, 2 and 3 clinical trials of multiple phase 1, 2 or 3 evaluating novel treatment strategies and agent in various cancer signalating patways. Dr André is on the trial management groups and trial steering groupsof multiple national or international phase 2-3 gastrointestinal trials. He has given invited lectures in mare than 20 countries. Dr André’s area research intersrest focus in cancers, harboring microsatellite instability / DNA mismatch repair deficiency. He is member of INSERM, Unité Mixte de Recherche Scientifique 938, Centre de Recherche Saint-Antoine, Equipe Instabilité des Microsatellites et Cancer, Equipe labellisée par la Ligue Nationale contre le Cancer, Paris 75012, France. He has published more than 260 peer-reviewed articles (H Index: 67; Citation 29 378) in prestigious journals including New England Journal of Medicine, Lancet, Lancet Oncology, JAMA, the Journal of Clinical Oncology, Annals of Oncology, Br J Cancer, Ann Surg Oncol and European journal of Oncology. Thierry André is Professor of Medical Oncology at University Sorbonne Universités, (Paris VI), in Paris and at the Head and a senior physician, of the Medical Oncology (GI Oncology) department in Saint Antoine Hospital, Assistance Publique Hôpitaux de Paris since 2011. He received his MD in 1991 and trained in medical oncology at the University of Paris. He is a Founder, and Vice President of GERCOR Group. He is president of the scientific comitee of the ARCAD foundation. He is member of the Adjuvant Colon Cancer Endpoints (ACCENT) Group, the American Society of Clinical Oncology (ASCO), and the European Society of Medical Oncology (ESMO). He served or as served on the ASCO, ESMO educational comitee. Professor André’s main research interest is GI malignancies, and particularly the treatment of colo-rectal cancer. Dr André is the chief or principal investigator of multiple phase1, 2 and 3 clinical trials of multiple phase 1, 2 or 3 evaluating novel treatment strategies and agent in various cancer signalating patways. Dr André is on the trial management groups and trial steering groupsof multiple national or international phase 2-3 gastrointestinal trials. He has given invited lectures in mare than 20 countries. Dr André’s area research intersrest focus in cancers, harboring microsatellite instability / DNA mismatch repair deficiency. He is member of INSERM, Unité Mixte de Recherche Scientifique 938, Centre de Recherche Saint-Antoine, Equipe Instabilité des Microsatellites et Cancer, Equipe labellisée par la Ligue Nationale contre le Cancer, Paris 75012, France. He has published more than 260 peer-reviewed articles (H Index: 67; Citation 29 378) in prestigious journals including New England Journal of Medicine, Lancet, Lancet Oncology, JAMA, the Journal of Clinical Oncology, Annals of Oncology, Br J Cancer, Ann Surg Oncol and European journal of Oncology.
  • : , ,

    {{group.getActive().startDate.year}}-{{group.getActive().startDate.month}}-{{group.getActive().startDate.day}} to present {{group.getActive().endDate.year}}-{{group.getActive().endDate.month}}-{{group.getActive().endDate.day}} {{group.getActive().endDate.year}}-{{group.getActive().endDate.month}}-{{group.getActive().endDate.day}} |  ()
    • Show Details Hide Details
    Organization identifiers
    {{group.getActive().orgDisambiguatedName}}: {{group.getActive().orgDisambiguatedCity}}, {{group.getActive().orgDisambiguatedRegion}}, {{group.getActive().orgDisambiguatedCountry}}
    Other organization identifiers provided by {{group.getActive().disambiguationSource.value}}
    • {{orgDisambiguatedExternalIdentifier.identifierType}}: {{orgDisambiguatedExternalIdentifier.preferred}} (preferred) ,
      {{orgDisambiguatedExternalIdentifierAll}}{{$last ? '' : ', '}}
    Created
    Source: {{(group.getActive().sourceName == null || group.getActive().sourceName == '') ? group.getActive().source : group.getActive().sourceName}}
No education added yet
  • : , ,

    {{group.getActive().startDate.year}}-{{group.getActive().startDate.month}}-{{group.getActive().startDate.day}} to present {{group.getActive().endDate.year}}-{{group.getActive().endDate.month}}-{{group.getActive().endDate.day}} {{group.getActive().endDate.year}}-{{group.getActive().endDate.month}}-{{group.getActive().endDate.day}} |  ()
    • Show Details Hide Details
    Organization identifiers
    {{group.getActive().orgDisambiguatedName}}: {{group.getActive().orgDisambiguatedCity}}, {{group.getActive().orgDisambiguatedRegion}}, {{group.getActive().orgDisambiguatedCountry}}
    Other organization identifiers provided by {{group.getActive().disambiguationSource.value}}
    • {{orgDisambiguatedExternalIdentifier.identifierType}}: {{orgDisambiguatedExternalIdentifier.preferred}} (preferred) ,
      {{orgDisambiguatedExternalIdentifierAll}}{{$last ? '' : ', '}}
    Created
    Source: {{(group.getActive().sourceName == null || group.getActive().sourceName == '') ? group.getActive().source : group.getActive().sourceName}}
No employment added yet
No publications added yet

Record last modified {{lastModifiedDate}}